Background and Aims: Cardiovascular disease (CVD), the leading cause of mortality in industrially developed countries, is primarily caused by atherosclerosis, characterized by an abnormal lipid and inflammatory cell accumulation in the intima, which is associated with atheroma plaque formation. The interaction of HDLs with membrane cholesterol transporters is especially relevant in reducing the intracellular cholesterol content of macrophages that interact with the atheroma plaque, thus HDL mimetics have focused attention as a potential therapeutic tool and as an inspirational source for biomedical engineering. The goal of the present work was to deliver microRNA to foam cells to stimulate ABCA1 expression in order to improve the previously shown effects of 1,2-dipalmitoyl-sn-glycerol-3-phosphocholine (DPPC) rHDL on promoting cholesterol efflux.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Atherosclerosis
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
P147 / #675 E-Posters Topic: 1. PATHOGENESIS OF ATHEROSCLEROSIS / 1.08 Atherosclerosis regression
© 2021 Published by Elsevier Inc.